Zoetis Inc. (ETR:ZOE)
121.98
-3.30 (-2.63%)
Oct 10, 2025, 5:35 PM CET
Zoetis Revenue
Zoetis had revenue of $2.46B USD in the quarter ending June 30, 2025, with 4.19% growth. This brings the company's revenue in the last twelve months to $9.39B, up 5.27% year-over-year. In the year 2024, Zoetis had annual revenue of $9.26B with 8.33% growth.
Revenue (ttm)
$9.39B
Revenue Growth
+5.27%
P/S Ratio
6.73
Revenue / Employee
$680.07K
Employees
13,800
Market Cap
53.80B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.26B | 712.00M | 8.33% |
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
Dec 31, 2018 | 5.83B | 518.00M | 9.76% |
Dec 31, 2017 | 5.31B | 419.00M | 8.57% |
Dec 31, 2016 | 4.89B | 123.00M | 2.58% |
Dec 31, 2015 | 4.77B | -20.00M | -0.42% |
Dec 31, 2014 | 4.79B | 224.00M | 4.91% |
Dec 31, 2013 | 4.56B | 225.00M | 5.19% |
Dec 31, 2012 | 4.34B | 103.00M | 2.43% |
Dec 31, 2011 | 4.23B | 651.00M | 18.17% |
Dec 31, 2010 | 3.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Zoetis News
- 1 day ago - Zoetis (ZTS): EMA Supports New Canine Osteoarthritis Treatment - GuruFocus
- 1 day ago - Zoetis (ZTS) Awaits EU Approval for Lenivia, an Osteoarthritis Treatment for Dogs - GuruFocus
- 1 day ago - Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs - Seeking Alpha
- 1 day ago - Zoetis Receives Positive Opinion from CVMP for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Wallstreet:Online
- 1 day ago - Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Business Wire
- 1 day ago - Daily Dividend Report: ZTS,DOW,R,PFE,LMT,NWN - Nasdaq
- 2 days ago - Zoetis Inc. (ZTS) Announces Fourth Quarter Dividend - GuruFocus
- 2 days ago - Zoetis (ZTS) Maintains Quarterly Dividend, Sets Payment Date - GuruFocus